Logo image of BN

BROOKFIELD CORP (BN) Stock Fundamental Analysis

USA - NYSE:BN - CA11271J1075 - Common Stock

68.23 USD
-0.48 (-0.7%)
Last: 10/6/2025, 11:24:06 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BN. BN was compared to 238 industry peers in the Capital Markets industry. While BN is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, BN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
BN had a positive operating cash flow in the past year.
BN had positive earnings in 4 of the past 5 years.
In the past 5 years BN always reported a positive cash flow from operatings.
BN Yearly Net Income VS EBIT VS OCF VS FCFBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

With a Return On Assets value of 0.13%, BN is not doing good in the industry: 75.21% of the companies in the same industry are doing better.
With a Return On Equity value of 1.45%, BN is not doing good in the industry: 72.27% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 3.69%, BN perfoms like the industry average, outperforming 48.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BN is below the industry average of 7.64%.
The last Return On Invested Capital (3.69%) for BN is above the 3 year average (3.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROIC 3.69%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN Yearly ROA, ROE, ROICBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BN has a Profit Margin of 0.89%. This is in the lower half of the industry: BN underperforms 72.69% of its industry peers.
In the last couple of years the Profit Margin of BN has declined.
BN has a Operating Margin (26.65%) which is comparable to the rest of the industry.
BN's Operating Margin has improved in the last couple of years.
BN has a Gross Margin of 37.81%. This is in the lower half of the industry: BN underperforms 65.97% of its industry peers.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN Yearly Profit, Operating, Gross MarginsBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

1

2. Health

2.1 Basic Checks

BN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BN remains at a similar level compared to 5 years ago.
BN has a worse debt/assets ratio than last year.
BN Yearly Shares OutstandingBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN Yearly Total Debt VS Total AssetsBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

BN has an Altman-Z score of 0.38. This is a bad value and indicates that BN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BN (0.38) is worse than 66.39% of its industry peers.
A Debt/Equity ratio of 4.50 is on the high side and indicates that BN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.50, BN is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACCN/A
BN Yearly LT Debt VS Equity VS FCFBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

A Current Ratio of 0.56 indicates that BN may have some problems paying its short term obligations.
BN's Current ratio of 0.56 is on the low side compared to the rest of the industry. BN is outperformed by 74.79% of its industry peers.
BN has a Quick Ratio of 0.56. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.47, BN is doing worse than 78.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.47
BN Yearly Current Assets VS Current LiabilitesBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.82% over the past year.
BN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.12% yearly.
BN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.85%.
The Revenue has been growing slightly by 4.86% on average over the past years.
EPS 1Y (TTM)0.82%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-34.81%
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%

3.2 Future

BN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.41% yearly.
The Revenue is expected to grow by 27.86% on average over the next years. This is a very strong growth
EPS Next Y-1.97%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
EPS Next 5YN/A
Revenue Next Year28.52%
Revenue Next 2Y35.57%
Revenue Next 3Y27.86%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN Yearly Revenue VS EstimatesBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN Yearly EPS VS EstimatesBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.39, the valuation of BN can be described as rather expensive.
BN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.86. BN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 14.66, BN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BN to the average of the S&P500 Index (23.32), we can say BN is valued slightly cheaper.
Industry RankSector Rank
PE 18.39
Fwd PE 14.66
BN Price Earnings VS Forward Price EarningsBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BN is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.64
BN Per share dataBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

A more expensive valuation may be justified as BN's earnings are expected to grow with 12.41% in the coming years.
PEG (NY)N/A
PEG (5Y)1.02
EPS Next 2Y8.29%
EPS Next 3Y12.41%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, BN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.50, BN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, BN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

The dividend of BN decreases each year by -3.57%.
BN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BN decreased recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN Yearly Dividends per shareBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

102.07% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP102.07%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
BN Yearly Income VS Free CF VS DividendBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN Dividend Payout.BN Dividend Payout, showing the Payout Ratio.BN Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

NYSE:BN (10/6/2025, 11:24:06 AM)

68.23

-0.48 (-0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners56.37%
Inst Owner Change0%
Ins Owners10.26%
Ins Owner ChangeN/A
Market Cap112.53B
Analysts76.84
Price Target74.97 (9.88%)
Short Float %1.56%
Short Ratio7.93
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.44
Dividend Growth(5Y)-3.57%
DP102.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-12 2025-09-12 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.36%
Max EPS beat(2)6.19%
EPS beat(4)2
Avg EPS beat(4)3.82%
Min EPS beat(4)-2.36%
Max EPS beat(4)11.75%
EPS beat(8)6
Avg EPS beat(8)12.81%
EPS beat(12)9
Avg EPS beat(12)-0.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1127.6%
Min Revenue beat(2)1118.53%
Max Revenue beat(2)1136.66%
Revenue beat(4)4
Avg Revenue beat(4)1262.07%
Min Revenue beat(4)1118.53%
Max Revenue beat(4)1473.07%
Revenue beat(8)8
Avg Revenue beat(8)846.78%
Revenue beat(12)12
Avg Revenue beat(12)582.41%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.29%
PT rev (3m)9.7%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)-1.23%
EPS NY rev (1m)0.22%
EPS NY rev (3m)-1.76%
Revenue NQ rev (1m)10.68%
Revenue NQ rev (3m)13.43%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE 18.39
Fwd PE 14.66
P/S 1.48
P/FCF N/A
P/OCF 11.13
P/B 2.42
P/tB N/A
EV/EBITDA 11.64
EPS(TTM)3.71
EY5.44%
EPS(NY)4.66
Fwd EY6.82%
FCF(TTM)-6.61
FCFYN/A
OCF(TTM)6.13
OCFY8.98%
SpS46.13
BVpS28.25
TBVpS-19.41
PEG (NY)N/A
PEG (5Y)1.02
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROCE 4.96%
ROIC 3.69%
ROICexc 3.82%
ROICexgc 4.77%
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexcg growth 3Y2.5%
ROICexcg growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Debt/EBITDA 6.97
Cap/Depr 213.98%
Cap/Sales 27.61%
Interest Coverage 250
Cash Conversion 33.59%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.47
Altman-Z 0.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-34.81%
EPS Next Y-1.97%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%
Revenue Next Year28.52%
Revenue Next 2Y35.57%
Revenue Next 3Y27.86%
Revenue Next 5YN/A
EBIT growth 1Y0.94%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year393.96%
EBIT Next 3Y70.07%
EBIT Next 5YN/A
FCF growth 1Y-8.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.06%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%